Explanation
Empag(iftozin
SGL2inhibitorstkeempaatifiozin bothrecucetheriskofcardiacfailureandischaemic cardiovascularevents.
Assuchthevarethemostappropriate intervention herefor apatient presentinq with amvocardiaL infarction
with evidenceofcardiacfailureagainstabackgroundofuncontrolledtvpe2diabetes.
@1MINENDOCRINE
